RecruitingEarly Phase 1NCT06417177

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

Sponsor

University of Missouri-Columbia

Enrollment

75 participants

Start Date

Jun 3, 2024

Study Type

INTERVENTIONAL

Conditions

Menopause Hypoxia Aging Vasodilation

Summary

The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gemtesa, a drug called Placebo, and others for people with aging, hypoxia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.